IHL Chart Technicals, page-22

As posted before, we are starting to see the next evolution of cannabis moving from commoditisation to specialist health care solutions. IHL has fully funded trials - note that Cannvalate (also dist for AGH) has chosen to partner with them with options at very high SP. Confidence. The value if these markets like concussion and Sleep Aponea (global problems) are massive and IHL posed to take IP leadership here.

Concussion trials will be very interesting - so topical.